Comparison of tissue distribution and fate of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and 1-beta-D-arabinofuranosyl-5-fluorocytosine in rats.
作者信息
Chou T C, Vidal P, Phillips F S
出版信息
Cancer Treat Rep. 1977 Jul;61(4):617-24.
PMID:69496
Abstract
摘要
相似文献
1
Comparison of tissue distribution and fate of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and 1-beta-D-arabinofuranosyl-5-fluorocytosine in rats.
Cancer Treat Rep. 1977 Jul;61(4):617-24.
2
3
Physiological disposition of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in humans.
Cancer Res. 1975 Sep;35(9):2453-60.
4
Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
Cancer Treat Rep. 1978 Mar;62(3):463-4.
5
Comparison of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and cytosine arabinoside in the treatment of murine brain tumor.
Cancer Treat Rep. 1976 Jul;60(7):875-9.
6
Fluorinated Pyrimidine nucleosides. 1. Synthesis of a nitrogen analogue of the antitumor agent 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine hydrochloride.
J Med Chem. 1977 Mar;20(3):344-8. doi: 10.1021/jm00213a006.
7
Physiologic disposition of cytosine arabinoside and its derivatives in man.
Cancer Treat Rep. 1977 Jul;61(4):723-6.
8
Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine.
J Pharm Sci. 1984 Jun;73(6):728-32. doi: 10.1002/jps.2600730606.
9
10
Physiological distribution of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine (AAFC) in man.
Ann N Y Acad Sci. 1975 Aug 8;255:213-5. doi: 10.1111/j.1749-6632.1975.tb29226.x.
Zotero 插件